BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 2774388)

  • 1. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone and torsade de pointes.
    Lazzara R
    Ann Intern Med; 1989 Oct; 111(7):549-51. PubMed ID: 2672929
    [No Abstract]   [Full Text] [Related]  

  • 5. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsade de pointes during loading with amiodarone.
    Leroy G; Haiat R; Barthelemy M; Lionnet F
    Eur Heart J; 1987 May; 8(5):541-3. PubMed ID: 3609047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.
    Kay GN; Plumb VJ; Arciniegas JG; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1983 Nov; 2(5):806-17. PubMed ID: 6630761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone-induced polymorphous ventricular tachycardia.
    Sclarovsky S; Lewin RF; Kracoff O; Strasberg B; Arditti A; Agmon J
    Am Heart J; 1983 Jan; 105(1):6-12. PubMed ID: 6849241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
    Lewis BH; Antman EM; Graboys TB
    J Am Coll Cardiol; 1983 Sep; 2(3):426-36. PubMed ID: 6192159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin.
    Aldariz AE; Romero H; Baroni M; Baglivo H; Esper RJ
    Pacing Clin Electrophysiol; 1986 Nov; 9(6):836-41. PubMed ID: 2432486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone and torsades de pointes in patients with advanced heart failure.
    Middlekauff HR; Stevenson WG; Saxon LA; Stevenson LW
    Am J Cardiol; 1995 Sep; 76(7):499-502. PubMed ID: 7653452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Torsade de pointes following intravenous infusion of amiodarone].
    Chinaglia A; Cibinel GA; Uslenghi E; Mangiardi L
    Cardiologia; 1989 Feb; 34(2):177-80. PubMed ID: 2736564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
    Roden DM; Woosley RL; Primm RK
    Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced ventricular fibrillation.
    McComb JM; Logan KR; Khan MM; Geddes JS; Adgey AA
    Eur J Cardiol; 1980; 11(5):381-5. PubMed ID: 7398728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsade de pointes after amiodarone withdrawal; effects of mild hypokalaemia on repolarization.
    Forfar JC; Gribbin B
    Eur Heart J; 1984 Jun; 5(6):510-2. PubMed ID: 6745293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
    Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent torsade de pointes type ventricular tachycardia in intracranial hemorrhage.
    Sen S; Stober T; Burger L; Anstätt T; Rettig G
    Intensive Care Med; 1984; 10(5):263-4. PubMed ID: 6491039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.